Package 69097-173-64

{"route": ["RESPIRATORY (INHALATION)"], "spl_id": "914605d4-7326-445d-b20e-6771eb67f7c4", "openfda": {"unii": ["021SEF3731", "J697UZ2A9J"], "rxcui": ["1437702"], "spl_set_id": ["3c64255e-074c-41f8-a344-3686a0685020"], "manufacturer_name": ["Cipla USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "6 POUCH in 1 CARTON (69097-173-53)  / 5 VIAL in 1 POUCH / 3 mL in 1 VIAL", "package_ndc": "69097-173-53", "marketing_start_date": "20071231"}, {"sample": false, "description": "12 POUCH in 1 CARTON (69097-173-64)  / 5 VIAL in 1 POUCH / 3 mL in 1 VIAL", "package_ndc": "69097-173-64", "marketing_start_date": "20071231"}], "brand_name": "Ipratropium Bromide and Albuterol Sulfate", "product_id": "69097-173_914605d4-7326-445d-b20e-6771eb67f7c4", "dosage_form": "SOLUTION", "pharm_class": ["Adrenergic beta2-Agonists [MoA]", "Anticholinergic [EPC]", "Cholinergic Antagonists [MoA]", "beta2-Adrenergic Agonist [EPC]"], "product_ndc": "69097-173", "generic_name": "Ipratropium Bromide and Albuterol Sulfate", "labeler_name": "Cipla USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ipratropium Bromide and Albuterol Sulfate", "active_ingredients": [{"name": "ALBUTEROL SULFATE", "strength": "2.5 mg/3mL"}, {"name": "IPRATROPIUM BROMIDE", "strength": ".5 mg/3mL"}], "application_number": "ANDA077559", "marketing_category": "ANDA", "marketing_start_date": "20071231", "listing_expiration_date": "20261231"}